// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

PFO Closure is Superior to Medical Therapy for Cryptogenic Stroke: a meta-analysis of randomised controlled trials

Yousif Ahmad - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Importance of Contrast Aortography with Lotus transcatheter aortic valve replacement – a post hoc analysis from the RESPOND Post-market Study

Lennart van Gils - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

In Vitro Optimisation of a Transcatheter Polymeric Aortic Valve

Paul De Sciscio - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical Implications of 3-Vessel Fractional Flow Reserve Measurement in Patients with Coronary Artery Disease

Joo Myung Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Hemodynamic changes after percutaneous coronary interventions of stenoses with discordant fractional flow reserve and coronary flow reserve

Gilbert Wijntjens - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical Outcomes of Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients Stratified by STS Score: Results from the SURTAVI Trial

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preterm premature rupture of the membranes

N/A

Functional Status after Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis from the SURTAVI Trial

Jeffrey J. Popma - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Clinical Outcomes of Deferred Lesions with Angiographically Insignificant Stenosis but Low Fractional Flow Reserve

Joo Myung Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Novel method to assess both the epicardial and microvascular domain using vascular conductance obtained from intracoronary pressure and flow velocity

Nina van der Hoeven - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Spontaneous Coronary Artery Dissection (SCAD) Is Not a Benign Entity: Analysis of 120 Patients in Brazilian SCAD Registry With a Long-Term Follow-Up

Jamil Cade - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Spontaneous coronary artery dissection

N/A

Four-Year Outcomes with the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve: Results from the REPRISE II Study

David Hildick-Smith - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Associations Between Baseline Atrial Fibrillation And Risk Of 1-Year Outcomes After Transcatheter Aortic Valve Replacement: Results From The WIN-TAVI Registry

Alaide Chieffo - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Three-year clinical outcome of Everolimus-eluting bioresorbable scaffold vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction - TROFI II trial

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Everolimus

Three Year Clinical Performance of the Dual-therapy COMBO stent: Insights from the REMEDEE Registry

Deborah Kalkman - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

sirolimus

Economic benefits of transradial percutaneous coronary intervention; a national analysis from the British Cardiovascular Intervention Society database

Mamas Mamas - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Technical safety and feasibility of coronary interventions in patients with prior self-expanding transcatheter aortic valve replacement

Akihito Tanaka - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Geographical Variation in Patient Characteristics, Procedures and Clinical Outcomes after PCI of Left Main Coronary Artery Disease: Analysis from the EXCEL Trial

Aung Myat - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Everolimus

Transcatheter aortic valve replacement for isolated severe native aortic valve regurgitation – results from the TAVR-NAVR Registry

Ole De Backer - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Shear stress analysis in multimodality imaging a sub-analysis of IBIS 4 study

Christos Bourantas - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Bilastine

Angiographic derived Endothelial Shear Stress: a new predictor of atherosclerotic disease progression

Michalis Hadjiandreou - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Bilastine

Copyright © 2026. QuantiNova All rights reserved